Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

Pharmaceuticals, 2024

Identification of Causal Genes and Potential Drug Targets for Restless Legs Syndrome: A Comprehensive Mendelian Randomization Study

Qian R., Zhao X., Lyu D. et al.

Journal of Translational Medicine, 2024

Genomic and clinical characterization of pediatric lymphoepithelioma-like carcinoma

Que Y., Lu X., Lu S. et al.

Bioactive Materials, 2024

Reprogramming of iPSCs to NPCEC-like cells by biomimetic scaffolds for zonular fiber reconstruction

Chen T., Chen Z., Du J. et al.

Neuropsychobiology, 2024

Cerebrospinal fluid biomarkers of central nervous system inflammation predict cortical decline in bipolar disorder and ventricular enlargement in healthy controls

Bellaagh Johansson T., Klahn A., Göteson A. et al.

Scientific Reports, 2024

Causal relationship between inflammatory proteins, immune cells, and gout: a Mendelian randomization study

Lai R., Deng X., Lv X. et al.

Frontiers in Medicine, 2024

Genetically predicted serum metabolites mediate the association between inflammatory proteins and polycystic ovary syndrome: a Mendelian randomization study

Jia M., Zhou L., Liu X. et al.

PLOS ONE, 2024

Microgravity’s effects on miRNA-mRNA regulatory networks in a mouse model of segmental bone defects

Gautam A., Chakraborty N., Dimitrov G. et al.

Journal of Allergy and Clinical Immunology, 2024

Features of hyperinflammation link the biology of EBV infection and cytokine storm syndromes

Liu M., Brodeur K., Bledsoe J. et al.

Medicine, 2024

Association between immune cell attributes, serum metabolites, inflammatory protein factors, and colorectal cancer: A Mendelian randomization study

Zhang J., Chen H., Yang R. et al.

Medicine, 2024

Causal relationships between immune cells, inflammatory cytokines, and pertussis: Bidirectional 2-sample Mendelian randomization study and mediation analysis

Lu F., Feng H., Wang J. et al.

Scientific Reports, 2024

Systemic inflammatory response in colorectal cancer is associated with tumour mismatch repair and impaired survival

Hjortborg M., Edin S., Böckelman C. et al.

Brain, Behavior, and Immunity, 2024

Plasma levels of matrix metalloproteinases in early psychosis, anxiety and depression: Evidence from the ALSPAC cohort

Ghelfi L., Mongan D., Susai S. et al.

Gland Surgery, 2024

Causal relationship between cathepsins and major salivary gland neoplasms: a bidirectional Mendelian randomization study

Zhuang S., Ding H., Huang H. et al.

International Journal of Dental Hygiene, 2024

Activation of the Urokinase Plasminogen Activator/Urokinase Plasminogen Activator Receptor System in Periodontitis: A Case–Control Study

Khudhur A., Dowson C., Bissett S. et al.

Cell Death Discovery, 2024

Cardiomyocyte and stromal cell cross-talk influences the pathogenesis of arrhythmogenic cardiomyopathy: a multi-level analysis uncovers DLK1-NOTCH pathway role in fibro-adipose remodelling

Maione A., Iengo L., Sala L. et al.

Autoimmunity, 2024

High throughput multiplex immunoassays stratify patients according to symptom burden across the anti-Ro positive systemic autoimmune rheumatic disease spectrum

Dyball S., Shukla R., Madenidou A. et al.

Advanced Science, 2024

Chemogenomic Screening in a Patient‐Derived 3D Fatty Liver Disease Model Reveals the CHRM1‐TRPM8 Axis as a Novel Module for Targeted Intervention

Youhanna S., Kemas A., Wright S. et al.

Diabetes/Metabolism Research and Reviews, 2024

Prediction Model for Polyneuropathy in Recent‐Onset Diabetes Based on Serum Neurofilament Light Chain, Fibroblast Growth Factor‐19 and Standard Anthropometric and Clinical Variables

Maalmi H., Nguyen P., Strom A. et al.

Scientific Reports, 2024

Interleukin-17A is a potential therapeutic target predicted by proteomics for systemic sclerosis patients at high risk of pulmonary arterial hypertension

Ono Y., Mogami A., Saito R. et al.

Proteome Science, 2024

Multi-targeted olink proteomics analyses of cerebrospinal fluid from patients with aneurysmal subarachnoid hemorrhage

Ding R., Wu L., Wei S. et al.

4586 publications